• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Waning of COVID-19 vaccine effectiveness: individual and public health risk.

作者信息

Piechotta Vanessa, Harder Thomas

机构信息

Robert Koch Institute, 13353 Berlin, Germany.

Robert Koch Institute, 13353 Berlin, Germany.

出版信息

Lancet. 2022 Mar 5;399(10328):887-889. doi: 10.1016/S0140-6736(22)00282-3. Epub 2022 Feb 23.

DOI:10.1016/S0140-6736(22)00282-3
PMID:35202602
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8863500/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5906/8863500/e53749f7627a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5906/8863500/e53749f7627a/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5906/8863500/e53749f7627a/fx1_lrg.jpg

相似文献

1
Waning of COVID-19 vaccine effectiveness: individual and public health risk.新冠病毒疫苗效力的减弱：个人与公共健康风险
Lancet. 2022 Mar 5;399(10328):887-889. doi: 10.1016/S0140-6736(22)00282-3. Epub 2022 Feb 23.
2
A log-odds system for waning and boosting of COVID-19 vaccine effectiveness.一种用于 COVID-19 疫苗效力衰减和增强的对数几率系统。
Vaccine. 2022 Jun 21;40(28):3821-3824. doi: 10.1016/j.vaccine.2022.05.039. Epub 2022 May 20.
3
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021.辉瑞-生物科技和 Moderna 疫苗在 SARS-CoV-2 B.1.617.2（Delta）变异株广泛传播之前和期间预防养老院居民感染 SARS-CoV-2 的有效性 - 国家医疗保健安全网络，2021 年 3 月 1 日至 8 月 1 日。
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1163-1166. doi: 10.15585/mmwr.mm7034e3.
4
The impact of COVID-19 vaccination programme in the Republic of San Marino: Focus on effectiveness of Gam-Covid-Vac.圣马力诺共和国 COVID-19 疫苗接种计划的影响：重点关注 Gam-Covid-Vac 的有效性。
Clin Microbiol Infect. 2022 Dec;28(12):1636-1643. doi: 10.1016/j.cmi.2022.06.026. Epub 2022 Jul 4.
5
An intranasal lentiviral booster reinforces the waning mRNA vaccine-induced SARS-CoV-2 immunity that it targets to lung mucosa.鼻内注射慢病毒加强针可增强正在减弱的、由mRNA疫苗诱导产生的、针对肺黏膜的SARS-CoV-2免疫力。
Mol Ther. 2022 Sep 7;30(9):2984-2997. doi: 10.1016/j.ymthe.2022.04.016. Epub 2022 Apr 27.
6
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States.美国针对奥密克戎BA.1变体的免疫力减弱和增强作用的数学评估。
Math Biosci Eng. 2023 Jan;20(1):179-212. doi: 10.3934/mbe.2023009. Epub 2022 Sep 30.
7
Implications of COVID-19 vaccine effectiveness waning for public health.新冠病毒疫苗效力减弱对公共卫生的影响
Lancet Infect Dis. 2022 Jul;22(7):918-919. doi: 10.1016/S1473-3099(22)00233-X. Epub 2022 Apr 22.
8
COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infections, COVID-19 related hospitalizations and deaths, among individuals aged ≥65 years in Portugal: A cohort study based on data-linkage of national registries February-September 2021.COVID-19 疫苗对≥65 岁人群中出现症状的 SARS-CoV-2 感染、COVID-19 相关住院和死亡的有效性：基于国家登记数据链接的 2021 年 2 月至 9 月的队列研究。
PLoS One. 2022 Sep 13;17(9):e0274008. doi: 10.1371/journal.pone.0274008. eCollection 2022.
9
Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective.从全球视角裁定 COVID-19 疫苗加强针的物流问题。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2020572. doi: 10.1080/21645515.2021.2020572. Epub 2022 Jan 13.
10
COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.COVID-19 疫苗效力下降和加强针的有效性和副作用：来自 ZOE COVID 研究的一项前瞻性社区研究。
Lancet Infect Dis. 2022 Jul;22(7):1002-1010. doi: 10.1016/S1473-3099(22)00146-3. Epub 2022 Apr 8.

引用本文的文献

1
European countries policy responses against SARS-Cov-2 in the context of vaccinations.欧洲国家在疫苗接种背景下针对新冠病毒的政策应对措施。
Sci Rep. 2025 Aug 18;15(1):30189. doi: 10.1038/s41598-025-11881-3.
2
Prenatal Maternal Immunization for Infant Protection: A Review of the Vaccines Recommended, Infant Immunity and Future Research Directions.为保护婴儿进行的产前母体免疫：推荐疫苗、婴儿免疫及未来研究方向综述
Pathogens. 2024 Feb 23;13(3):200. doi: 10.3390/pathogens13030200.
3
An analysis of the waning effect of COVID-19 vaccinations.

本文引用的文献

1
Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.家庭环境中 SARS-CoV-2 变异株的二次感染率及其与疫苗接种状态的关系：一项更新的系统评价和荟萃分析。
JAMA Netw Open. 2022 Apr 1;5(4):e229317. doi: 10.1001/jamanetworkopen.2022.9317.
2
Protection by a Fourth Dose of BNT162b2 against Omicron in Israel.在以色列，第四剂 BNT162b2 对奥密克戎的保护作用。
N Engl J Med. 2022 May 5;386(18):1712-1720. doi: 10.1056/NEJMoa2201570. Epub 2022 Apr 5.
3
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
新冠疫苗接种效果减弱情况分析。
Genomics Inform. 2023 Dec;21(4):e50. doi: 10.5808/gi.23088. Epub 2023 Dec 29.
4
A two-arm analysis of the immune response to heterologous boosting of inactivated SARS-CoV-2 vaccines.两臂分析对灭活 SARS-CoV-2 疫苗异源加强的免疫反应。
Sci Rep. 2023 Oct 31;13(1):18762. doi: 10.1038/s41598-023-46053-8.
5
First Do No Harm? Modeling Risks and Benefits of Challenge Trials for Hepatitis C Vaccine Development.首先不造成伤害？为丙型肝炎疫苗开发建模风险和获益挑战试验。
Clin Infect Dis. 2023 Aug 14;77(Suppl 3):S231-S237. doi: 10.1093/cid/ciad379.
6
Threshold conditions for curbing COVID-19 with a dynamic zero-case policy derived from 101 outbreaks in China.运用中国 101 起疫情数据推算出的动态清零政策遏制新冠疫情的阈值条件。
BMC Public Health. 2023 Jun 6;23(1):1084. doi: 10.1186/s12889-023-16009-8.
7
A population-based paediatric Covid-19 vaccination progress and outcomes: The Malta case.基于人群的儿童新冠疫苗接种进展与结果：马耳他案例
Ethics Med Public Health. 2023 Jun;28:100901. doi: 10.1016/j.jemep.2023.100901. Epub 2023 Apr 4.
8
"Having vaccines is good but not enough": Requirements for optimal COVID-19 immunization program in Vietnam.“接种疫苗有益但还不够”：越南最佳新冠病毒免疫计划的要求
Front Public Health. 2023 Mar 9;11:1137401. doi: 10.3389/fpubh.2023.1137401. eCollection 2023.
9
In Vitro Diagnostic Assay to Detect SARS-CoV-2-Neutralizing Antibody in Patient Sera Using Engineered ACE-2 Mini-Protein.使用工程化 ACE-2 小蛋白检测患者血清中 SARS-CoV-2 中和抗体的体外诊断检测方法。
Viruses. 2022 Dec 18;14(12):2823. doi: 10.3390/v14122823.
10
Assessing the impact of the four COVID-19 variants and the vaccine coverage on mortality in Malta over 2 years: An observational case study.评估 COVID-19 四种变异株和疫苗接种覆盖率对马耳他两年内死亡率的影响：一项观察性病例研究。
Front Public Health. 2022 Sep 23;10:1018505. doi: 10.3389/fpubh.2022.1018505. eCollection 2022.
疫苗预防严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）感染和 COVID-19 疾病有效性的持续时间：系统评价和荟萃回归的结果。
Lancet. 2022 Mar 5;399(10328):924-944. doi: 10.1016/S0140-6736(22)00152-0. Epub 2022 Feb 23.
4
Three, four or more: what's the magic number for booster shots?三剂、四剂还是更多剂：加强针的神奇数字是多少？
Nature. 2022 Feb;602(7895):17-18. doi: 10.1038/d41586-022-00200-9.
5
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.mRNA-1273 新型冠状病毒疫苗在盲法阶段完成时的效力。
N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22.
6
Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil.在巴西第二波新冠疫情期间公共卫生系统的崩溃以及新变种的出现。
One Health. 2021 Dec;13:100287. doi: 10.1016/j.onehlt.2021.100287. Epub 2021 Jun 29.